GrantRover ↗

← All opportunities

Defense Health Agency Contracting Activity - DHACA · United States

DoW Breast Cancer, Clinical Research Extension Award

Open

Defense Health Agency Contracting Activity - DHACA expects to make 1 award, from a total budget of $8.4 million. Applications close on 18 Nov 2026. Eligible applicant types include unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility".

Deadline
18 Nov 2026 (in 3 days)
Grant amount
$8.4 million (one award)
Funding rate
No mandatory cost sharing stated; funding percentage not stated
Total budget
$8.4 million
Expected awards
1
Cost sharing
Not required
Likely applicant types
Companies, SMEs / start-ups, Non-profits, Universities & research, Public bodies, Individuals From source categories or programme rules; the call decides.
Funder
Defense Health Agency Contracting Activity - DHACA
Reference
HT942526BCRPCREA2
Assistance listing
12.420 Military Medical Research and Development
Last checked
13 Nov 2026

Open the official call ↗ Add deadline to calendar

About this call

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.

Distinctive Features:

• The research team must include two or more breast cancer consumer advocates.

• This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Who can apply

Applicant categories are a starting point. The official call decides eligibility.

Topics

Science and Technology and other Research and Development

How to apply

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. Register with Grants.gov and set up a Workspace for this opportunity, with the right roles for your organisation.
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

Contact

Danielle Reckley · help@eBRAP.org · 301-619-1139

Where these facts come from

FactValueHow we knowTaken from the source
Deadline18 November 2026official data field15 Nov 2026
Amount per applicantUnknown — not stated in the source we holdunknown—
Total budget$8.4 millionofficial data field15 Nov 2026
Funding rateNo mandatory cost sharing stated; funding percentage not statedread from the official text15 Nov 2026
Who can applyUnrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"official data field15 Nov 2026
Where to applyUnknown — not stated in the source we holdunknown—

Official sources

Official call page

Facts on this page come from the funder’s official data, taken on 13 Nov 2026. The funder's own documents, including later amendments, always take precedence.

More from Defense Health Agency Contracting Activity - DHACA

Defense Health Agency Contracting Activity - DHACA United States

DoW Joint Warfighter Medical, Military Medical Research and Development Award

HT942526JWMRPMMRDA

Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fu…

Defense Health Agency Contracting Activity - DHACA United States

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

HT942526BCRPBTA122

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make…

Defense Health Agency Contracting Activity - DHACA United States

DOW Combat Readiness – Medical Research Program Translational Research Award

HT942526CRRPTRA

Summary: The fiscal year 2026 (FY26) Combat Readiness – Medical Research Program (CRRP) Translational Research Award (TRA) supports hypothesis-driven innovative, high-imp…

Defense Health Agency Contracting Activity - DHACA United States

DoW Orthopaedic, Applied Research Award

HT942526ORPARA

Summary: The Orthopaedic Research Program (ORP) Applied Research Award (ARA) seeks applied research applications focused on advancing optimal treatment and restoration of…

Defense Health Agency Contracting Activity - DHACA United States

DoW Orthopaedic, Clinical Research Award

HT942526ORPCRA

Summary: The fiscal year 2026 (FY26) Orthopaedic Research Program (ORP) Clinical Research Award (CRA) seeks clinical research that evaluates orthopaedic-specific factors …